Megan Furnari, MD, MS in Portland, OR - Medicare Pediatrics

Megan Furnari, MD, MS is a medicare enrolled "Pediatrics - Neonatal-perinatal Medicine" physician in Portland, Oregon. Her current practice location is 3181 Sw Sam Jackson Park Road, Portland, Oregon. You can reach out to her office (for appointments etc.) via phone at (503) 494-8211.

Megan Furnari is licensed to practice in Oregon (license number MD177568) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1003159757.

Contact Information

	Megan Furnari, MD, MS
	3181 Sw Sam Jackson Park Road, Portland, OR 97239
	(503) 494-8211
	Not Available

Physician's Profile

Full Name	Megan Furnari
Gender	Female
Speciality	Pediatrics - Neonatal-perinatal Medicine
Location	3181 Sw Sam Jackson Park Road, Portland, Oregon
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1003159757
Provider Enumeration Date: 04/01/2013
Last Update Date: 06/07/2016

Medicare PECOS Information:

PECOS PAC ID: 4284925066
Enrollment ID: I20160627000303

Medical Identifiers

Medical identifiers for Megan Furnari such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1003159757	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
2080N0001X	Pediatrics - Neonatal-perinatal Medicine	MD177568 (Oregon)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Megan Furnari allows following entities to bill medicare on her behalf.

Entity Name	University Professional Services
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013

News Archive

New genes involved in rheumatoid arthritis discovered

Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

GlaxoSmithKline today announced that the United States Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) voted unanimously in support of the approval of VOTRIENT(TM) (pazopanib). Specifically, the panel voted that the benefit-to-risk profile is acceptable for patients with advanced renal cell carcinoma (RCC). Pazopanib is an investigational, oral treatment for patients with advanced RCC.

First physician affiliated with Renaissance Health Systems goes live with PWeR

The Quantum Group, Inc. announced today that the first physician affiliated with Quantum subsidiary Renaissance Health Systems has "gone live" with PWeR™ (Personal Wellness electronic Record™), the one patient, one record™ electronic medical record platform offered by Quantum Innovations, Inc.

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Researchers in the UK and United States have demonstrated the efficacy of one dose of either the Pfizer-BioNTech or Oxford-AstraZeneca vaccine against infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a real-world community setting in the UK.

Entity Name	Tuality Medical Group Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1073929782 PECOS PAC ID: 7416173414 Enrollment ID: O20140729000238

New genes involved in rheumatoid arthritis discovered

Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Entity Name	Portland Adventist Medical Center
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1750091021 PECOS PAC ID: 3274908819 Enrollment ID: O20230412001327

New genes involved in rheumatoid arthritis discovered

Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Megan Furnari is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Megan Furnari, MD, MS 3181 Sw Sam Jackson Park Road, Portland, OR 97239 Ph: (503) 494-8211	Megan Furnari, MD, MS 3181 Sw Sam Jackson Park Road, Portland, OR 97239 Ph: (503) 494-8211

News Archive

New genes involved in rheumatoid arthritis discovered

Researchers at the University of Manchester have identified evidence of several new genes behind the chronic inflammatory disease rheumatoid arthritis (RA), which affects 387,000 people in the UK.

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Pediatrics Doctors in Portland, OR

Dr. Sharon Sarah Green Gorini, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3181 Southwest Sam Jackson Park Road, Oregon Health And Science University Mail-dc9r, Portland, OR 97239 Phone: 503-418-5170
Bruce Alan Boston, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-1926
Dr. Karin Ann Selva, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 501 N Graham St, Suite 375, Portland, OR 97227 Phone: 503-413-1600
Dr. Peter H Chang, DO Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 300 N Graham St Ste 250, Portland, OR 97227 Phone: 503-280-3418 Fax: 503-284-7885
George W Bengtson, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4212 Ne Broadway St, Portland, OR 97213 Phone: 503-249-8787
Dr. Amanda K Blockinger Bailey, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6234 N Greeley Ave, Sellwood Medical Clinic, Portland, OR 97217 Phone: 503-595-9300

Megan Furnari, MD, MS - Medicare Pediatrics in Portland, OR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

New genes involved in rheumatoid arthritis discovered

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

New genes involved in rheumatoid arthritis discovered

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

New genes involved in rheumatoid arthritis discovered

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

New genes involved in rheumatoid arthritis discovered

FDA's Oncologic Drugs Advisory Committee recommends approval of GlaxoSmithKline's VOTRIENT

First physician affiliated with Renaissance Health Systems goes live with PWeR

Safety and efficacy of Pfizer and AstraZeneca COVID-19 vaccines even better than clinical trials predicted

Pediatrics Doctors in Portland, OR